Neutrophils: important contributors to tumor progression and metastasis
The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
The presence of neutrophils in tumors has traditionally been considered to be indicative of a failed immune response against cancers. However, there is now evidence showing that neutrophils can promote tumor growth, and increasingly, the data support an active role for neutrophils in tumor progression to distant metastasis. Neutrophils have been implicated in promoting metastasis in cancer patients, where neutrophil numbers and neutrophil-related factors and functions have been associated with progressive disease. Nevertheless, the role of neutrophils in tumors, both at the primary and secondary sites, remains controversial, with some studies reporting their anti-tumor functions. This review will focus on the data demonstrating a role for neutrophils in both tumor growth and metastasis and will attempt to clarify the discrepancies in the literature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neutrophils represent a significant portion of cells in the TME (Swierczak et al., 2015; Powell and Huttenlocher, 2016), and their abundance has been linked to adverse prognostic outcomes in cancer patients (Hiramatsu et al., 2018; Schiffmann et al., 2019; Yin et al., 2019; Kim et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Swierczak et al., 2015
In the citing paper
“Neutrophils constitute a significant portion of the immune cells present within a TIME [4–8]”
Citations
Cites
Items 201–223 of 223
Selective reduction of human tumor cell populations by human granulocytes in vitro.
Chee, D. O., Townsend, C. M., Galbraith, M. A., Eilber, F. R., & Morton, D. L. (1978) · PubMed · Cited by 42
Inoue, T., & Sendo, F. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2508 · Cited by 42 · cited 1×
“In most cases, however, this cytotoxicity was elicited after neutrophils were primed with bacterial products or inflammatory agents [65] or after the immune system was primed and subsequently activated by injections of large numbers of the same tumor cells [6].”
BackgroundRoxburgh, C. S. D., Wallace, A. M., Guthrie, G., Horgan, P. G., & McMillan, D. C. (2009) · Colorectal Disease · doi:10.1111/j.1463-1318.2009.01961.x · Cited by 38
Lichtenstein, A. K. (1987) · PubMed · Cited by 36
Yui, S., Tomita, K., Kudo, T., Ando, S., & Yamazaki, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00097.x · Cited by 34
Augmentation of B16 melanoma lung colony formation in C57BL/6 mice having marked granulocytosis
Ishikawa, M., Koga, Y., Hosokawa, M., & Kobayashi, H. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370619 · Cited by 34 · cited 3×
“Inflammation at the primary tumor site [2] and at metastatic sites [169] increases the likelihood of successful metastasis [76, 170].”
BackgroundEffects of a murine mammary tumor on in vivo and in vitro hemopoiesis
Johnson, G. R., Nicola, N. A., & Whitehead, R. (1985) · The International Journal Of Cell Cloning · doi:10.1002/stem.5530030203 · Cited by 31
Morimoto‐Kamata, R., Mizoguchi, S.-I., Ichisugi, T., & Yui, S. (2012) · Mediators of Inflammation · doi:10.1155/2012/456462 · Cited by 31 · cited 1×
“Neutrophils can promote aggregation of MCF-7 cells in vitro [180, 181], but the hypothesis that neutrophil-mediated aggregation of tumor cells supports metastasis has yet to be verified in vivo (Fig.”
BackgroundSanford, M. A., Yan, Y., Canfield, S. E., Hassan, W. N., Selleck, W. A., Atkinson, G., Chen, S., & Hall, S. J. (2001) · Human Gene Therapy · doi:10.1089/10430340152480221 · Cited by 31
Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro
Wilkinson, D., Sandhu, J., Breneman, J. W., Jd, T., & Birnboim, H. C. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.492 · Cited by 31
Stimulating natural killer cells to protect against cancer: recent developments
Gillgrass, A. E., & Ashkar, A. A. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.102 · Cited by 31
Austen, K. F., Burakoff, S. J., Rosen, F. S., Strom, T. B., & Robinson, J. A. (1996) · Shock · doi:10.1097/00024382-199612000-00011 · Cited by 29
Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
Kershaw, M. H., Trapani, J. A., & Smyth, M. J. (1995) · PubMed · Cited by 26
Revisiting the protective and pathogenic roles of neutrophils: Ly‐6G is key!
Bao, Y., & Cao, X. (2011) · European Journal of Immunology · doi:10.1002/eji.201141979 · Cited by 22 · cited 1×
“in experiments using Gr-1 antibodies need to be re-evaluated [44, 45].”
MethodEarly Hematopoietic Events During Tumor Growth in Mice 2
Hardy, C. L., & Balducci, L. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/76.3.535 · Cited by 17
Kondo, M., Kato, H., Yoshikawa, T., & Sugino, S. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90007-x · Cited by 15 · cited 1×
“Early studies indicated that TANs are toxic to human tumor cells in vitro [60, 61] and in vivo [62–64].”
BackgroundDefective antibody-dependent tumour cell lysis by neutrophils from cancer patients.
Dallegri, F., Ballestrero, A., Ottonello, L. C., & Patrone, F. (1989) · PubMed Central · Cited by 14
It is possible that tumour-infiltrating granulocytes promote tumour progression
Liu (2009) · Oncology Reports · doi:10.3892/or_00000402 · Cited by 14 · cited 2×
“gastric carcinomas, TANs were reported to be concentrated at the invasive front of the tumor [96].”
BackgroundGadducci, A., Sergiampietri, C., & Guiggi, I. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.801446 · Cited by 11 · cited 1×
“However, most antiVEGF therapies have been only moderately effective in the clinic, although new therapies and therapeutic protocols continue to emerge [202].”
BackgroundPolymorphonuclear cells stimulate the migration and metastatic potential of rat sarcoma cells
Remedi, M. M., Donadío, A. C., & Chiabrando, G. A. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00628.x · Cited by 10 · cited 1×
“shown to contribute to the metastatic process in a number of tumor models [9, 40, 69, 75, 143, 189, 211].”
BackgroundUbukata, H., Konishi, S., Nagata, H., Kasuga, N., Watanabe, Y., Goto, Y., Nakada, I., & Tabuchi, T. (2010) · Digestive Surgery · doi:10.1159/000308461 · Cited by 7
Aeed, P. A., & Welch, D. R. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.302 · Cited by 3 · cited 1×
“capacity of rat adenocarcinomas [69] and that the neutrophils derived from metastatic tumor-bearing mice were unable to lyse tumor cells [70].”
BackgroundThe participation of natural cytotoxicity in the control of malignant disease.
Draca, S. (1993) · PubMed · Cited by 1
Cited by
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
“Neutrophils play important and contradictory roles in cancer development, as reflected by several recent reviews (Sionov et al., 2015; Swierczak et al., 2015; Uribe-Querol and Rosales, 2015; Coffelt et al., 2016; Mishalian et al., 2017).”
BackgroundTumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01146 · Cited by 649
“macrophages, TANs may acquire either an antitumor activity (N1 neutrophils), either a pro-tumor activity (N2 neutrophils) (3, 7, 8).”
BackgroundThe Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Neutrophils in cancer: prognostic role and therapeutic strategies
Ocana, A., Nieto-Jiménez, C., Pandiella, A., & Templeton, A. J. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0707-7 · Cited by 459
“Neutrophil lifespan is altered in cancer and it is associated with maturation, extending from 7 h in normal conditions to 17 h in cancer [8, 9].”
BackgroundPrognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
Metadata
- Authors
- Swierczak, A., Mouchemore, K. A., Hamilton, J. A., & Anderson, R. L.
- Affiliations
- The Royal Melbourne Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- The University of Melbourne (AU)
- Corresponding author
- Anderson, Robin L.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2015-09-11
- Volume
- 34
- Issue
- 4
- Pages
- 735-751
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1722843651
- Cited by
- 220
- References
- 221
- Citations by year
- 2026: 5 · 2025: 23 · 2024: 21 · 2023: 31 · 2022: 29 · 2021: 28 · 2020: 32 · 2019: 17 · 2018: 17 · 2017: 11 · 2016: 5 · 2015: 1
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer and Metastasis Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Breast Cancer Foundation
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- neutrophils, tumor progression, metastasis, tumor growth, tumor microenvironment, tumor immunology
- MeSH terms
- Humans, Macrophages, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Neutrophils, Prognosis, T-Lymphocytes, Biomarkers, Tumor, Disease Progression, Neutrophil Infiltration, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.